Moreover, a recent research has found a self‐crosslinkable chitosan–HA dialdehyde nanoparticles could target the delivery of siRNA to T24 bladder cancer cells, which could affect bladder cancer through the interaction of CD44 and HA.289. This evidence concerns the gene CD44 and urinary bladder carcinoma.